Total	428 Artículos Disponibles
Fecha	Mon Jan 22 09:34:58 2007

Titulo	Autores	Fuentes
Pregnancy-associated malaria: Parasite binding, natural immunity and vaccine development.	'Gamain B', 'Smith JD', 'Viebig NK', 'Gysin J', 'Scherf A'	Int J Parasitol. 2006 Dec 22;.
Plasmodium sporozoites trickle out of the injection site.	['Yamauchi LM', 'Coppi A', 'Snounou G', 'Sinnis P']	Cell Microbiol. 2007 Jan 11;.
Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1.	['Collins CR', 'Withers-Martinez C', 'Bentley GA', 'Batchelor AH', 'Thomas AW', 'Blackman MJ']	J Biol Chem. 2006 Dec 27;.
RTS,S/AS02A for malaria.	['Bojang KA']	Expert Rev Vaccines. 2006 Oct;5(5):611-5.
Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway.	['Costa FT', 'Avril M', 'Nogueira PA', 'Gysin J']	Braz J Med Biol Res. 2006 Dec;39(12):1525-36.
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.	['Kumar KA', 'Sano G', 'Boscardin S', 'Nussenzweig RS', 'Nussenzweig MC', 'Zavala F', 'Nussenzweig V']	Nature. 2006 Dec 14;444(7121):937-40. Epub 2006 Dec 6.
Murine immune responses to Liver Stage Antigen-1 (FMP011), a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.	['Brando C', 'Ware LA', 'Freyberger H', 'Kathcart A', 'Barbosa A', 'Cayphas S', 'Domoitie MA', 'Mettens P', 'Heppner DG', 'Lanar DE']	Infect Immun. 2006 Nov 13;.
Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies.	['Avril M', 'Gamain B', 'Lepolard C', 'Viaud N', 'Scherf A', 'Gysin J']	Microbes Infect. 2006 Nov-Dec;8(14-15):2863-71. Epub 2006 Oct 17.
CTL response to pre-erythrocytic stage vaccine candidate of plasmodium falciparum in HLA-A*0201 transgenic mice detected by ELISPOT assay.	['Qian F', 'Zhang QF', 'Shen LH', 'Pan WQ']	Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2006 Aug;24(4):319-20, inside back cover.
Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.	['Moll K', 'Pettersson F', 'Vogt AM', 'Jonsson C', 'Rasti N', 'Ahuja S', 'Spangberg M', 'Mercereau-Puijalon O', 'Arnot DE', 'Wahlgren M', 'Chen Q']	Infect Immun. 2007 Jan;75(1):211-9. Epub 2006 Oct 30.
Vaccines for preventing malaria (pre-erythrocytic).	['Graves P', 'Gelband H']	Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006198.
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya.	['Bejon P', 'Mwacharo J', 'Kai O', 'Mwangi T', 'Milligan P', 'Todryk S', 'Keating S', 'Lang T', 'Lowe B', 'Gikonyo C', 'Molyneux C', 'Fegan G', 'Gilbert SC', 'Peshu N', 'Marsh K', 'Hill AV']	PLoS Clin Trials. 2006 Oct 20;1(6):e29.
Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.	['Pattnaik P', 'Shakri AR', 'Singh S', 'Goel S', 'Mukherjee P', 'Chitnis CE']	Vaccine. 2007 Jan 15;25(5):806-13. Epub 2006 Sep 27.
Immunological responses of neonates and infants to DNA vaccines.	['Sedegah M', 'Hoffman SL']	Methods Mol Med. 2006;127:239-51.
Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens.	['Bergmann-Leitner ES', 'Duncan EH', 'Mullen GE', 'Burge JR', 'Khan F', 'Long CA', 'Angov E', 'Lyon JA']	Am J Trop Med Hyg. 2006 Sep;75(3):437-42.
Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.	['Rasti N', 'Namusoke F', 'Chene A', 'Chen Q', 'Staalsoe T', 'Klinkert MQ', 'Mirembe F', 'Kironde F', 'Wahlgren M']	Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13795-800. Epub 2006 Aug 31.
Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania.	['Tediosi F', 'Hutton G', 'Maire N', 'Smith TA', 'Ross A', 'Tanner M']	Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):131-43.
Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa.	['Maire N', 'Tediosi F', 'Ross A', 'Smith T']	Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):111-8.
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.	['Stewart VA', 'McGrath SM', 'Walsh DS', 'Davis S', 'Hess AS', 'Ware LA', 'Kester KE', 'Cummings JF', 'Burge JR', 'Voss G', 'Delchambre M', 'Garcon N', 'Tang DB', 'Cohen JD', 'Heppner DG Jr']	Vaccine. 2006 Oct 30;24(42-43):6483-92. Epub 2006 Jul 3.
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production.	['Eksi S', 'Czesny B', 'van Gemert GJ', 'Sauerwein RW', 'Eling W', 'Williamson KC']	Mol Microbiol. 2006 Aug;61(4):991-8.
Transcribed var genes associated with placental malaria in Malawian women.	['Duffy MF', 'Caragounis A', 'Noviyanti R', 'Kyriacou HM', 'Choong EK', 'Boysen K', 'Healer J', 'Rowe JA', 'Molyneux ME', 'Brown GV', 'Rogerson SJ']	Infect Immun. 2006 Aug;74(8):4875-83.
Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.	['Bejon P', 'Kai OK', 'Mwacharo J', 'Keating S', 'Lang T', 'Gilbert SC', 'Peshu N', 'Marsh K', 'Hill AV']	Eur J Immunol. 2006 Aug;36(8):2264-72.
Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind.	['Alonso PL']	Int Microbiol. 2006 Jun;9(2):83-93.
Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).	['Rosa DS', 'Iwai LK', 'Tzelepis F', 'Bargieri DY', 'Medeiros MA', 'Soares IS', 'Sidney J', 'Sette A', 'Kalil J', 'Mello LE', 'Cunha-Neto E', 'Rodrigues MM']	Microbes Infect. 2006 Jul;8(8):2130-7. Epub 2006 Jun 2.
Vaccine development against malaria.	['Matuschewski K']	Curr Opin Immunol. 2006 Aug;18(4):449-57. Epub 2006 Jun 12.
Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated polypeptide in yeast.	['Zhang ZG', 'Yu WG', 'Qiu WS', 'Zhao HM']	Acta Biochim Biophys Sin (Shanghai). 2006 Jun;38(6):403-9.
Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.	['Persson KE', 'Lee CT', 'Marsh K', 'Beeson JG']	J Clin Microbiol. 2006 May;44(5):1665-73.
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.	['Duffy MF', 'Maier AG', 'Byrne TJ', 'Marty AJ', 'Elliott SR', "O'Neill MT", 'Payne PD', 'Rogerson SJ', 'Cowman AF', 'Crabb BS', 'Brown GV']	Mol Biochem Parasitol. 2006 Aug;148(2):117-24. Epub 2006 Apr 7.
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.	['Bejon P', 'Mwacharo J', 'Kai OK', 'Todryk S', 'Keating S', 'Lang T', 'Gilbert SC', 'Peshu N', 'Marsh K', 'Hill AV']	Vaccine. 2006 May 29;24(22):4709-15. Epub 2006 Mar 31.
Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum.	['Gilson PR', 'Nebl T', 'Vukcevic D', 'Moritz RL', 'Sargeant T', 'Speed TP', 'Schofield L', 'Crabb BS']	Mol Cell Proteomics. 2006 Jul;5(7):1286-99. Epub 2006 Apr 7.
Functional genomics, new tools in malaria research.	['Di Girolamo F', 'Raggi C', 'Bultrini E', 'Lanfrancotti A', 'Silvestrini F', 'Sargiacomo M', 'Birago C', 'Pizzi E', 'Alano P', 'Ponzi M']	Ann Ist Super Sanita. 2005;41(4):469-77.
Pre-erythrocytic malaria vaccines: towards greater efficacy.	['Hill AV']	Nat Rev Immunol. 2006 Jan;6(1):21-32.
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.	['Webster DP', 'Dunachie S', 'McConkey S', 'Poulton I', 'Moore AC', 'Walther M', 'Laidlaw SM', 'Peto T', 'Skinner MA', 'Gilbert SC', 'Hill AV']	Vaccine. 2006 Apr 5;24(15):3026-34. Epub 2006 Feb 2.
Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.	['Jongco AM', 'Ting LM', 'Thathy V', 'Mota MM', 'Kim K']	Mol Biochem Parasitol. 2006 Apr;146(2):242-50. Epub 2006 Jan 17.
Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.	['Makobongo MO', 'Keegan B', 'Long CA', 'Miller LH']	J Infect Dis. 2006 Mar 1;193(5):731-40. Epub 2006 Jan 30.
Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.	['Walther M']	Expert Rev Vaccines. 2006 Feb;5(1):81-93.
Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers.	['Sacci JB Jr', 'Alam U', 'Douglas D', 'Lewis J', 'Tyrrell DL', 'Azad AF', 'Kneteman NM']	Int J Parasitol. 2006 Mar;36(3):353-60.
Immune effector mechanisms in malaria.	['Marsh K', 'Kinyanjui S']	Parasite Immunol. 2006 Jan-Feb;28(1-2):51-60.
Protective and pathogenic roles of CD8+ T cells during malaria infection.	['Hafalla JC', 'Cockburn IA', 'Zavala F']	Parasite Immunol. 2006 Jan-Feb;28(1-2):15-24.
Antigen presentation and dendritic cell biology in malaria.	['Stevenson MM', 'Urban BC']	Parasite Immunol. 2006 Jan-Feb;28(1-2):5-14.
Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19).	['Zhang ZH', 'Jiang PH', 'Li NJ', 'Shi M', 'Huang W']	World J Gastroenterol. 2005 Nov 28;11(44):6975-80.
Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta.	['Fried M', 'Domingo GJ', 'Gowda CD', 'Mutabingwa TK', 'Duffy PE']	Exp Parasitol. 2006 May;113(1):36-42. Epub 2006 Jan 23.
Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.	['Woehlbier U', 'Epp C', 'Kauth CW', 'Lutz R', 'Long CA', 'Coulibaly B', 'Kouyate B', 'Arevalo-Herrera M', 'Herrera S', 'Bujard H']	Infect Immun. 2006 Feb;74(2):1313-22.
Sequence polymorphisms in the receptor-binding domain of Plasmodium falciparum EBA-175: implications for malaria vaccine development.	['Mamillapalli A', 'Pattnaik P', 'Sharma M', 'Sharma SK', 'Tyagi PK', 'Joshi H', 'Chitnis CE']	Mol Biochem Parasitol. 2006 Mar;146(1):120-3. Epub 2005 Dec 1.
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.	['Alonso PL', 'Sacarlal J', 'Aponte JJ', 'Leach A', 'Macete E', 'Aide P', 'Sigauque B', 'Milman J', 'Mandomando I', 'Bassat Q', 'Guinovart C', 'Espasa M', 'Corachan S', 'Lievens M', 'Navia MM', 'Dubois MC', 'Menendez C', 'Dubovsky F', 'Cohen J', 'Thompson R', 'Ballou WR']	Lancet. 2005 Dec 10;366(9502):2012-8.
Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.	'Moore AC', 'Gallimore A', 'Draper SJ', 'Watkins KR', 'Gilbert SC', 'Hill AV'	J Immunol. 2005 Dec 1;175(11):7264-73.
Aotus lemurinus griseimembra monkeys: a suitable model for Plasmodium vivax sporozoite infection.	['Jordan-Villegas A', 'Zapata JC', 'Perdomo AB', 'Quintero GE', 'Solarte Y', 'Arevalo-Herrera M', 'Herrera S']	Am J Trop Med Hyg. 2005 Nov;73(5 Suppl):10-5.
Early interactions between blood-stage plasmodium parasites and the immune system.	['Urban BC', 'Ing R', 'Stevenson MM']	Curr Top Microbiol Immunol. 2005;297:25-70.
The dissection of CD8 T cells during liver-stage infection.	['Krzych U', 'Schwenk J']	Curr Top Microbiol Immunol. 2005;297:1-24.
Functional proteome and expression analysis of sporozoites and hepatic stages of malaria development.	['Blair PL', 'Carucci DJ']	Curr Top Microbiol Immunol. 2005;295:417-38.
Host receptors in malaria merozoite invasion.	['Oh SS', 'Chishti AH']	Curr Top Microbiol Immunol. 2005;295:203-32.
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.	['Druilhe P', 'Spertini F', 'Soesoe D', 'Corradin G', 'Mejia P', 'Singh S', 'Audran R', 'Bouzidi A', 'Oeuvray C', 'Roussilhon C']	PLoS Med. 2005 Nov;2(11):e344. Epub 2005 Nov 8.
Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum.	['Sanders PR', 'Gilson PR', 'Cantin GT', 'Greenbaum DC', 'Nebl T', 'Carucci DJ', 'McConville MJ', 'Schofield L', 'Hodder AN', 'Yates JR 3rd', 'Crabb BS']	J Biol Chem. 2005 Dec 2;280(48):40169-76. Epub 2005 Oct 3.
Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.	['Zhang D', 'Pan W']	Infect Immun. 2005 Oct;73(10):6530-6.
Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.	['Sharma SK', 'Farah D', 'Misra-Bhattacharya S', 'Bajpai P', 'Agarwal A', 'Mohammad O']	Vaccine. 2006 Feb 13;24(7):948-56. Epub 2005 Aug 31.
Identification, cloning, expression, and characterization of the gene for Plasmodium knowlesi surface protein containing an altered thrombospondin repeat domain.	['Mahajan B', 'Jani D', 'Chattopadhyay R', 'Nagarkatti R', 'Zheng H', 'Majam V', 'Weiss W', 'Kumar S', 'Rathore D']	Infect Immun. 2005 Sep;73(9):5402-9.
The Plasmodium sporozoite survives RTS,S vaccination.	['Snounou G', 'Gruner AC', 'Muller-Graf CD', 'Mazier D', 'Renia L']	Trends Parasitol. 2005 Oct;21(10):456-61.
Reflections on the continuous cultivation of Plasmodium falciparum.	['Jensen JB']	J Parasitol. 2005 Jun;91(3):487-91.
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum.	['Tolia NH', 'Enemark EJ', 'Sim BK', 'Joshua-Tor L']	Cell. 2005 Jul 29;122(2):183-93.
Plasmodium parasite proteins and the infected erythrocyte.	['Haldar K', 'Hiller NL', 'van Ooij C', 'Bhattacharjee S']	Trends Parasitol. 2005 Sep;21(9):402-3.
How malaria has affected the human genome and what human genetics can teach us about malaria.	['Kwiatkowski DP']	Am J Hum Genet. 2005 Aug;77(2):171-92. Epub 2005 Jul 6.
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.	['Bojang KA', 'Olodude F', 'Pinder M', 'Ofori-Anyinam O', 'Vigneron L', 'Fitzpatrick S', 'Njie F', 'Kassanga A', 'Leach A', 'Milman J', 'Rabinovich R', 'McAdam KP', 'Kester KE', 'Heppner DG', 'Cohen JD', 'Tornieporth N', 'Milligan PJ']	Vaccine. 2005 Jul 14;23(32):4148-57. Epub 2005 Apr 15.
Erythrocyte variants and the nature of their malaria protective effect.	['Min-Oo G', 'Gros P']	Cell Microbiol. 2005 Jun;7(6):753-63.
Building better T-cell-inducing malaria vaccines.	['Todryk SM', 'Walther M']	Immunology. 2005 Jun;115(2):163-9.
Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax.	['Jalah R', 'Sarin R', 'Sud N', 'Alam MT', 'Parikh N', 'Das TK', 'Sharma YD']	Mol Biochem Parasitol. 2005 Aug;142(2):158-69. Epub 2005 Apr 26.
Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.	['Patarroyo ME', 'Alba MP', 'Vargas LE', 'Silva Y', 'Rosas J', 'Rodriguez R']	Biochemistry. 2005 May 10;44(18):6745-54.
Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.	['Scorza T', 'Grubb K', 'Smooker P', 'Rainczuk A', 'Proll D', 'Spithill TW']	Infect Immun. 2005 May;73(5):2974-85.
Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion.	['Vera-Bravo R', 'Valbuena JJ', 'Ocampo M', 'Garcia JE', 'Rodriguez LE', 'Puentes A', 'Lopez R', 'Curtidor H', 'Torres E', 'Trujillo M', 'Tovar DR', 'Patarroyo MA', 'Patarroyo ME']	Biochimie. 2005 May;87(5):425-36.
A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.	['Meraldi V', 'Romero JF', 'Kensil C', 'Corradin G']	Vaccine. 2005 Apr 15;23(21):2801-12.
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.	['Heppner DG Jr', 'Kester KE', 'Ockenhouse CF', 'Tornieporth N', 'Ofori O', 'Lyon JA', 'Stewart VA', 'Dubois P', 'Lanar DE', 'Krzych U', 'Moris P', 'Angov E', 'Cummings JF', 'Leach A', 'Hall BT', 'Dutta S', 'Schwenk R', 'Hillier C', 'Barbosa A', 'Ware LA', 'Nair L', 'Darko CA', 'Withers MR', 'Ogutu B', 'Polhemus ME', 'Fukuda M', 'Pichyangkul S', 'Gettyacamin M', 'Diggs C', 'Soisson L', 'Milman J', 'Dubois MC', 'Garcon N', 'Tucker K', 'Wittes J', 'Plowe CV', 'Thera MA', 'Duombo OK', 'Pau MG', 'Goudsmit J', 'Ballou WR', 'Cohen J']	Vaccine. 2005 Mar 18;23(17-18):2243-50.
A new Apicomplexa-specific protein kinase family: multiple members in Plasmodium falciparum, all with an export signature.	['Schneider AG', 'Mercereau-Puijalon O']	BMC Genomics. 2005 Mar 7;6(1):30.
Getting down to malarial nuts and bolts: the interaction between Plasmodium vivax merozoites and their host erythrocytes.	['Rayner J']	Mol Microbiol. 2005 Mar;55(5):1297-9.
Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.	['Korten S', 'Anderson RJ', 'Hannan CM', 'Sheu EG', 'Sinden R', 'Gadola S', 'Taniguchi M', 'Hill AV']	Infect Immun. 2005 Feb;73(2):849-58.
Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103.	['Pearce JA', 'Mills K', 'Triglia T', 'Cowman AF', 'Anders RF']	Mol Biochem Parasitol. 2005 Feb;139(2):141-51.
The importance of the spleen in malaria.	['Engwerda CR', 'Beattie L', 'Amante FH']	Trends Parasitol. 2005 Feb;21(2):75-80.
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.	['Darko CA', 'Angov E', 'Collins WE', 'Bergmann-Leitner ES', 'Girouard AS', 'Hitt SL', 'McBride JS', 'Diggs CL', 'Holder AA', 'Long CA', 'Barnwell JW', 'Lyon JA']	Infect Immun. 2005 Jan;73(1):287-97.
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.	['Vuola JM', 'Keating S', 'Webster DP', 'Berthoud T', 'Dunachie S', 'Gilbert SC', 'Hill AV']	J Immunol. 2005 Jan 1;174(1):449-55.
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.	['Walther M', 'Dunachie S', 'Keating S', 'Vuola JM', 'Berthoud T', 'Schmidt A', 'Maier C', 'Andrews L', 'Andersen RF', 'Gilbert S', 'Poulton I', 'Webster D', 'Dubovsky F', 'Tierney E', 'Sarpotdar P', 'Correa S', 'Huntcooke A', 'Butcher G', 'Williams J', 'Sinden RE', 'Thornton GB', 'Hill AV']	Vaccine. 2005 Jan 4;23(7):857-64.
Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry.	['Tran TM', 'Moreno A', 'Yazdani SS', 'Chitnis CE', 'Barnwell JW', 'Galinski MR']	Cytometry A. 2005;63(1):59-66.
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.	['Mueller AK', 'Labaied M', 'Kappe SH', 'Matuschewski K']	Nature. 2005 Jan 13;433(7022):164-7. Epub 2004 Dec 5.
Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.	['Leung WH', 'Meng ZQ', 'Hui G', 'Ho WK']	Biochim Biophys Acta. 2004 Nov 18;1675(1-3):62-70.
Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines.	['Smith JD', 'Deitsch KW']	J Exp Med. 2004 Nov 1;200(9):1093-7.
High-throughput generation of P. falciparum functional molecules by recombinational cloning.	['Aguiar JC', 'LaBaer J', 'Blair PL', 'Shamailova VY', 'Koundinya M', 'Russell JA', 'Huang F', 'Mar W', 'Anthony RM', 'Witney A', 'Caruana SR', 'Brizuela L', 'Sacci JB Jr', 'Hoffman SL', 'Carucci DJ']	Genome Res. 2004 Oct;14(10B):2076-82.
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
['Alonso PL', 'Sacarlal J', 'Aponte JJ', 'Leach A', 'Macete E', 'Milman J', 'Mandomando I', 'Spiessens B', 'Guinovart C', 'Espasa M', 'Bassat Q', 'Aide P', 'Ofori-Anyinam O', 'Navia MM', 'Corachan S', 'Ceuppens M', 'Dubois MC', 'Demoitie MA', 'Dubovsky F', 'Menendez C', 'Tornieporth N', 'Ballou WR', 'Thompson R', 'Cohen J']	Lancet. 2004 Oct 16-22;364(9443):1411-20.
Orally delivered malaria vaccines: not too hard to swallow.	['Wang L', 'Webster DE', 'Wesselingh SL', 'Coppel RL']	Expert Opin Biol Ther. 2004 Oct;4(10):1585-94.
A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.	['Rainczuk A', 'Scorza T', 'Spithill TW', 'Smooker PM']	Infect Immun. 2004 Oct;72(10):5565-73.
Immunity of peritoneal monocytes against Plasmodium yoelii infected erythrocytes.	['Mao YH', 'Yuan J', 'Liu BF']	Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Aug;26(4):415-7.
Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis.	['Lozano JM', 'Espejo F', 'Ocampo M', 'Salazar LM', 'Tovar D', 'Barrera N', 'Guzman F', 'Patarroyo ME']	J Struct Biol. 2004 Oct;148(1):110-22.
Does malaria suffer from lack of memory?	['Struik SS', 'Riley EM']	Immunol Rev. 2004 Oct;201:268-90.
The immunological challenge to developing a vaccine to the blood stages of malaria parasites.	['Good MF', 'Stanisic D', 'Xu H', 'Elliott S', 'Wykes M']	Immunol Rev. 2004 Oct;201:254-67.
Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.	['Sharling L', 'Enevold A', 'Sowa KM', 'Staalsoe T', 'Arnot DE']	Malar J. 2004 Sep 6;3:31.
The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites.	['Rajeshwari K', 'Patel K', 'Nambeesan S', 'Mehta M', 'Sehgal A', 'Chakraborty T', 'Sharma S']	Infect Immun. 2004 Sep;72(9):5515-21.
Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.	['Pouniotis DS', 'Proudfoot O', 'Bogdanoska V', 'Apostolopoulos V', 'Fifis T', 'Plebanski M']	Infect Immun. 2004 Sep;72(9):5331-9.
Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.	['Yazdani SS', 'Shakri AR', 'Mukherjee P', 'Baniwal SK', 'Chitnis CE']	Vaccine. 2004 Sep 9;22(27-28):3727-37.
Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.	['Bruna-Romero O', 'Rocha CD', 'Tsuji M', 'Gazzinelli RT']	Vaccine. 2004 Sep 9;22(27-28):3575-84.
Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.	['Hermsen CC', 'de Vlas SJ', 'van Gemert GJ', 'Telgt DS', 'Verhage DF', 'Sauerwein RW']	Am J Trop Med Hyg. 2004 Aug;71(2):196-201.
Transmission-blocking vaccine candidate of Plasmodium vivax Pvs25 is highly conservative among Chinese isolates.	['Zheng L', 'Xu WM', 'Liu YJ', 'Yang YM', 'Cao YM']	Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2004 Feb 28;22(1):16-9.
Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.	['Lalitha PV', 'Ware LA', 'Barbosa A', 'Dutta S', 'Moch JK', 'Haynes JD', 'Fileta BB', 'White CE', 'Lanar DE']	Infect Immun. 2004 Aug;72(8):4464-70.
Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.	['BenMohamed L', 'Thomas A', 'Druilhe P']	Infect Immun. 2004 Aug;72(8):4376-84.
Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes.	['Chen Q', 'Pettersson F', 'Vogt AM', 'Schmidt B', 'Ahuja S', 'Liljestrom P', 'Wahlgren M']	Vaccine. 2004 Jul 29;22(21-22):2701-12.
Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax.	['Suphavilai C', 'Looareesuwan S', 'Good MF']	Am J Trop Med Hyg. 2004 Jul;71(1):29-39.
Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.	['John CC', "O'Donnell RA", 'Sumba PO', 'Moormann AM', 'de Koning-Ward TF', 'King CL', 'Kazura JW', 'Crabb BS']	J Immunol. 2004 Jul 1;173(1):666-72.
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.	['Moorthy VS', 'Imoukhuede EB', 'Keating S', 'Pinder M', 'Webster D', 'Skinner MA', 'Gilbert SC', 'Walraven G', 'Hill AV']	J Infect Dis. 2004 Jun 15;189(12):2213-9. Epub 2004 May 24.
Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro.	['Preiser P', 'Renia L', 'Singh N', 'Balu B', 'Jarra W', 'Voza T', 'Kaneko O', 'Blair P', 'Torii M', 'Landau I', 'Adams JH']	Infect Immun. 2004 Jun;72(6):3604-8.
Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection.	['Topolska AE', 'Richie TL', 'Nhan DH', 'Coppel RL']	Infect Immun. 2004 Jun;72(6):3325-30.
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.	['Jensen AT', 'Magistrado P', 'Sharp S', 'Joergensen L', 'Lavstsen T', 'Chiucchiuini A', 'Salanti A', 'Vestergaard LS', 'Lusingu JP', 'Hermsen R', 'Sauerwein R', 'Christensen J', 'Nielsen MA', 'Hviid L', 'Sutherland C', 'Staalsoe T', 'Theander TG']	J Exp Med. 2004 May 3;199(9):1179-90.
Pregnancy-associated malaria--on the brink?	['Craig AG']	Trends Parasitol. 2004 May;20(5):201-4.
"Hide-and-seek" as modus vivendi of malaria parasites.	['Nascutiu AM']	Roum Arch Microbiol Immunol. 2002 Oct-Dec;61(4):301-14.
Plasmodium vivax and Plasmodium falciparum gametocyte stages are neglected in vaccine development.	['Contreras-Ochoa C', 'Ramsey JM']	Salud Publica Mex. 2004 Jan-Feb;46(1):64-70.
Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii.	['Yuan J', 'Xu B', 'Liu BF']	Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Feb;26(1):47-51.
Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites.	['Fried M', 'Wendler JP', 'Mutabingwa TK', 'Duffy PE']	Proteomics. 2004 Apr;4(4):1086-93.
Malaria vaccine: are we anywhere close?	['Raghunath D']	J Postgrad Med. 2004 Jan-Mar;50(1):51-4.
PTRAMP; a conserved Plasmodium thrombospondin-related apical merozoite protein.	['Thompson J', 'Cooke RE', 'Moore S', 'Anderson LF', 'Janse CJ', 'Waters AP']	Mol Biochem Parasitol. 2004 Apr;134(2):225-32.
Plasmodium falciparum: red blood cell binding studies using peptides derived from rhoptry-associated protein 2 (RAP2).	['Lopez R', 'Valbuena J', 'Curtidor H', 'Puentes A', 'Rodriguez LE', 'Garcia J', 'Suarez J', 'Vera R', 'Ocampo M', 'Trujillo M', 'Ramirez LE', 'Patarroyo ME']	Biochimie. 2004 Jan;86(1):1-6.
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.	['Anderson RJ', 'Hannan CM', 'Gilbert SC', 'Laidlaw SM', 'Sheu EG', 'Korten S', 'Sinden R', 'Butcher GA', 'Skinner MA', 'Hill AV']	J Immunol. 2004 Mar 1;172(5):3094-100.
Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.	['Taylor DW', 'Zhou A', 'Marsillio LE', 'Thuita LW', 'Leke EB', 'Branch O', 'Gowda DC', 'Long C', 'Leke RF']	Infect Immun. 2004 Mar;72(3):1603-7.
Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria.	['Espejo F', 'Bermudez A', 'Torres E', 'Urquiza M', 'Rodriguez R', 'Lopez Y', 'Patarroyo ME']	Biochem Biophys Res Commun. 2004 Mar 5;315(2):418-27.
Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.	['Belnoue E', 'Costa FT', 'Frankenberg T', 'Vigario AM', 'Voza T', 'Leroy N', 'Rodrigues MM', 'Landau I', 'Snounou G', 'Renia L']	J Immunol. 2004 Feb 15;172(4):2487-95.
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.	['Staalsoe T', 'Shulman CE', 'Bulmer JN', 'Kawuondo K', 'Marsh K', 'Hviid L']	Lancet. 2004 Jan 24;363(9405):283-9.
Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes.	['Casey JL', 'Coley AM', 'Anders RF', 'Murphy VJ', 'Humberstone KS', 'Thomas AW', 'Foley M']	Infect Immun. 2004 Feb;72(2):1126-34.
CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.	['Kumar S', 'Jones TR', 'Oakley MS', 'Zheng H', 'Kuppusamy SP', 'Taye A', 'Krieg AM', 'Stowers AW', 'Kaslow DC', 'Hoffman SL']	Infect Immun. 2004 Feb;72(2):949-57.
Relationship of binding of immunoglobulin G to Plasmodium falciparum-infected erythrocytes with parasite endemicity and antibody responses to conserved antigen in immune individuals.	['Diatta AM', 'Marrama L', 'Tall A', 'Trape JF', 'Dieye A', 'Garraud O', 'Mercereau-Puijalon O', 'Perraut R']	Clin Diagn Lab Immunol. 2004 Jan;11(1):6-11.
A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.	['Cockburn IA', 'Mackinnon MJ', "O'Donnell A", 'Allen SJ', 'Moulds JM', 'Baisor M', 'Bockarie M', 'Reeder JC', 'Rowe JA']	Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):272-7. Epub 2003 Dec 23.
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.	['Mitchell GH', 'Thomas AW', 'Margos G', 'Dluzewski AR', 'Bannister LH']	Infect Immun. 2004 Jan;72(1):154-8.
Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.	['Sun P', 'Schwenk R', 'White K', 'Stoute JA', 'Cohen J', 'Ballou WR', 'Voss G', 'Kester KE', 'Heppner DG', 'Krzych U']	J Immunol. 2003 Dec 15;171(12):6961-7.
Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.	['Singh S', 'Kennedy MC', 'Long CA', 'Saul AJ', 'Miller LH', 'Stowers AW']	Infect Immun. 2003 Dec;71(12):6766-74.
A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3.	['Li X', 'Chen H', 'Oo TH', 'Daly TM', 'Bergman LW', 'Liu SC', 'Chishti AH', 'Oh SS']	J Biol Chem. 2004 Feb 13;279(7):5765-71. Epub 2003 Nov 20.
How many pathways for invasion of the red blood cell by the malaria parasite?	['Pasvol G']	Trends Parasitol. 2003 Oct;19(10):430-2.
Progress in the development of recombinant and synthetic blood-stage malaria vaccines.	['Mahanty S', 'Saul A', 'Miller LH']	J Exp Biol. 2003 Nov;206(Pt 21):3781-8.
Parasitology. Guilty until proven otherwise.	['Waters AP']	Science. 2003 Sep 12;301(5639):1487-8.
Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems.	['Yadava A', 'Ockenhouse CF']	Infect Immun. 2003 Sep;71(9):4961-9.
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.	['Bozdech Z', 'Llinas M', 'Pulliam BL', 'Wong ED', 'Zhu J', 'DeRisi JL']	PLoS Biol. 2003 Oct;1(1):E5. Epub 2003 Aug 18.
Molecular cloning of Plasmodium yoelii dynamin-like protein (PyDyn) gene and the immunological character of its domains.	['Wang D', 'Mao YH', 'Wang H']	Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Apr;25(2):176-80.
Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.	['Taylor-Robinson AW']	Expert Rev Vaccines. 2002 Oct;1(3):317-40.
Recovery of adhesion to chondroitin-4-sulphate in Plasmodium falciparum varCSA disruption mutants by antigenically similar PfEMP1 variants.	['Andrews KT', 'Pirrit LA', 'Przyborski JM', 'Sanchez CP', 'Sterkers Y', 'Ricken S', 'Wickert H', 'Lepolard C', 'Avril M', 'Scherf A', 'Gysin J', 'Lanzer M']	Mol Microbiol. 2003 Aug;49(3):655-69.
Association of interferon-gamma responses to pre-erythrocytic stage vaccine candidate antigens of Plasmodium falciparum in young Kenyan children with improved hemoglobin levels: XV. Asembo Bay Cohort Project.	["Ong'echa JM", 'Lal AA', 'Terlouw DJ', 'Ter Kuile FO', 'Kariuki SK', 'Udhayakumar V', 'Orago AS', 'Hightower AW', 'Nahlen BL', 'Shi YP']	Am J Trop Med Hyg. 2003 May;68(5):590-7.
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.	['McConkey SJ', 'Reece WH', 'Moorthy VS', 'Webster D', 'Dunachie S', 'Butcher G', 'Vuola JM', 'Blanchard TJ', 'Gothard P', 'Watkins K', 'Hannan CM', 'Everaere S', 'Brown K', 'Kester KE', 'Cummings J', 'Williams J', 'Heppner DG', 'Pathan A', 'Flanagan K', 'Arulanantham N', 'Roberts MT', 'Roy M', 'Smith GL', 'Schneider J', 'Peto T', 'Sinden RE', 'Gilbert SC', 'Hill AV']	Nat Med. 2003 Jun;9(6):729-35. Epub 2003 May 25.
Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy.	['Mitamura T', 'Palacpac NM']	Microbes Infect. 2003 May;5(6):545-52.
The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites.	['Schmieg J', 'Gonzalez-Aseguinolaza G', 'Tsuji M']	Microbes Infect. 2003 May;5(6):499-506.
Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.	['Angov E', 'Aufiero BM', 'Turgeon AM', 'Van Handenhove M', 'Ockenhouse CF', 'Kester KE', 'Walsh DS', 'McBride JS', 'Dubois MC', 'Cohen J', 'Haynes JD', 'Eckels KH', 'Heppner DG', 'Ballou WR', 'Diggs CL', 'Lyon JA']	Mol Biochem Parasitol. 2003 May;128(2):195-204.
Immunogenicity and protective efficacy of Plasmodium falciparum liver-stage Ag-3 in Aotus lemurinus griseimembra monkeys.	['Perlaza BL', 'Zapata C', 'Valencia AZ', 'Hurtado S', 'Quintero G', 'Sauzet JP', 'Brahimi K', 'Blanc C', 'Arevalo-Herrera M', 'Druilhe P', 'Herrera S']	Eur J Immunol. 2003 May;33(5):1321-7.
Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.	['Pizarro JC', 'Chitarra V', 'Verger D', 'Holm I', 'Petres S', 'Dartevelle S', 'Nato F', 'Longacre S', 'Bentley GA']	J Mol Biol. 2003 May 16;328(5):1091-103.
PfSPATR, a Plasmodium falciparum protein containing an altered thrombospondin type I repeat domain is expressed at several stages of the parasite life cycle and is the target of inhibitory antibodies.	['Chattopadhyay R', 'Rathore D', 'Fujioka H', 'Kumar S', 'de la Vega P', 'Haynes D', 'Moch K', 'Fryauff D', 'Wang R', 'Carucci DJ', 'Hoffman SL']	J Biol Chem. 2003 Jul 11;278(28):25977-81. Epub 2003 Apr 25.
MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.	['Lozano JM', 'Alba MP', 'Vanegas M', 'Silva Y', 'Torres-Castellanos JL', 'Patarroyo ME']	Biol Chem. 2003 Jan;384(1):71-82.
Influence of deleting 9 amino acid residues at N-terminus on immunogenicity of a Plasmodium falciparum chimeric protein.	['Zhang QF', 'Pan WQ', 'Qu L', 'Xue XY']	Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Apr;35(4):345-9.
Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways.	['Duraisingh MT', 'Maier AG', 'Triglia T', 'Cowman AF']	Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4796-801. Epub 2003 Apr 2.
Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia.	['Baum J', 'Pinder M', 'Conway DJ']	Infect Immun. 2003 Apr;71(4):1856-63.
Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.	['Sakai T', 'Hisaeda H', 'Nakano Y', 'Zhang M', 'Takashima M', 'Ishii K', 'Maekawa Y', 'Matsumoto S', 'Nitta Y', 'Miyazaki J', 'Yamamoto S', 'Himeno K']	Vaccine. 2003 Mar 28;21(13-14):1432-44.
Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome.	['Robinson BA', 'Welch TL', 'Smith JD']	Mol Microbiol. 2003 Mar;47(5):1265-78.
A malaria vaccine candidate based on a hepatitis B virus core platform.	['Sallberg M', 'Hughes J', 'Jones J', 'Phillips TR', 'Milich DR']	Intervirology. 2002;45(4-6):350-61.
T cells as mediators of protective immunity against liver stages of Plasmodium.	['Tsuji M', 'Zavala F']	Trends Parasitol. 2003 Feb;19(2):88-93.
Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments.	['Espinosa AM', 'Sierra AY', 'Barrero CA', 'Cepeda LA', 'Cantor EM', 'Lombo TB', 'Guzman F', 'Avila SJ', 'Patarroyo MA']	Vaccine. 2003 Mar 7;21(11-12):1033-43.
CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum.	['Smith TG', 'Serghides L', 'Patel SN', 'Febbraio M', 'Silverstein RL', 'Kain KC']	Infect Immun. 2003 Jan;71(1):393-400.
Structure of the C-terminal domains of merozoite surface protein-1 from Plasmodium knowlesi reveals a novel histidine binding site.	['Garman SC', 'Simcoke WN', 'Stowers AW', 'Garboczi DN']	J Biol Chem. 2003 Feb 28;278(9):7264-9. Epub 2002 Dec 19.
Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.	['Persson C', 'Oliveira GA', 'Sultan AA', 'Bhanot P', 'Nussenzweig V', 'Nardin E']	J Immunol. 2002 Dec 15;169(12):6681-5.
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.	['Stowers AW', 'Kennedy MC', 'Keegan BP', 'Saul A', 'Long CA', 'Miller LH']	Infect Immun. 2002 Dec;70(12):6961-7.
Malaria pathogenesis: a jigsaw with an increasing number of pieces.	['Heddini A']	Int J Parasitol. 2002 Dec 4;32(13):1587-98.
Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment.	['Li J', 'Mitamura T', 'Fox BA', 'Bzik DJ', 'Horii T']	Parasitol Int. 2002 Dec;51(4):343-52.
Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.	['Lasonder E', 'Ishihama Y', 'Andersen JS', 'Vermunt AM', 'Pain A', 'Sauerwein RW', 'Eling WM', 'Hall N', 'Waters AP', 'Stunnenberg HG', 'Mann M']	Nature. 2002 Oct 3;419(6906):537-42.
A proteomic view of the Plasmodium falciparum life cycle.	['Florens L', 'Washburn MP', 'Raine JD', 'Anthony RM', 'Grainger M', 'Haynes JD', 'Moch JK', 'Muster N', 'Sacci JB', 'Tabb DL', 'Witney AA', 'Wolters D', 'Wu Y', 'Gardner MJ', 'Holder AA', 'Sinden RE', 'Yates JR', 'Carucci DJ']	Nature. 2002 Oct 3;419(6906):520-6.
The Plasmodium falciparum genome--a blueprint for erythrocyte invasion.	['Cowman AF', 'Crabb BS']	Science. 2002 Oct 4;298(5591):126-8.
Susceptibility to malaria as a complex trait: big pressure from a tiny creature.	['Fortin A', 'Stevenson MM', 'Gros P']	Hum Mol Genet. 2002 Oct 1;11(20):2469-78.
Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth.	['Aoki S', 'Li J', 'Itagaki S', 'Okech BA', 'Egwang TG', 'Matsuoka H', 'Palacpac NM', 'Mitamura T', 'Horii T']	J Biol Chem. 2002 Dec 6;277(49):47533-40. Epub 2002 Sep 18.
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.	['Pombo DJ', 'Lawrence G', 'Hirunpetcharat C', 'Rzepczyk C', 'Bryden M', 'Cloonan N', 'Anderson K', 'Mahakunkijcharoen Y', 'Martin LB', 'Wilson D', 'Elliott S', 'Elliott S', 'Eisen DP', 'Weinberg JB', 'Saul A', 'Good MF']	Lancet. 2002 Aug 24;360(9333):610-7.
Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.	['Carvalho LJ', 'Daniel-Ribeiro CT', 'Goto H']	Scand J Immunol. 2002 Oct;56(4):327-43.
A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle.	['Miller SK', 'Good RT', 'Drew DR', 'Delorenzi M', 'Sanders PR', 'Hodder AN', 'Speed TP', 'Cowman AF', 'de Koning-Ward TF', 'Crabb BS']	J Biol Chem. 2002 Dec 6;277(49):47524-32. Epub 2002 Sep 11.
Immunity to asexual blood stage malaria and vaccine approaches.	['Wipasa J', 'Elliott S', 'Xu H', 'Good MF']	Immunol Cell Biol. 2002 Oct;80(5):401-14.
Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.	['Jones TR', 'Stroncek DF', 'Gozalo AS', 'Obaldia N 3rd', 'Andersen EM', 'Lucas C', 'Narum DL', 'Magill AJ', 'Sim BK', 'Hoffman SL']	Am J Trop Med Hyg. 2002 Jun;66(6):672-9.
Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys.	['Bhardwaj D', 'Hora B', 'Singh N', 'Puri SK', 'Lalitha P', 'Rupa P', 'Chauhan VS']	FEMS Immunol Med Microbiol. 2002 Sep 6;34(1):33-43.
Identification, expression, and functional characterization of MAEBL, a sporozoite and asexual blood stage chimeric erythrocyte-binding protein of Plasmodium falciparum.	['Ghai M', 'Dutta S', 'Hall T', 'Freilich D', 'Ockenhouse CF']	Mol Biochem Parasitol. 2002 Aug 7;123(1):35-45.
Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.	['Pandey KC', 'Singh S', 'Pattnaik P', 'Pillai CR', 'Pillai U', 'Lynn A', 'Jain SK', 'Chitnis CE']	Mol Biochem Parasitol. 2002 Aug 7;123(1):23-33.
Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.	['Lekana Douki JB', 'Traore B', 'Costa FT', 'Fusai T', 'Pouvelle B', 'Sterkers Y', 'Scherf A', 'Gysin J']	Blood. 2002 Aug 15;100(4):1478-83.
Maternal malaria: Plasmodium falciparum sequestration in the placenta.	['Andrews KT', 'Lanzer M']	Parasitol Res. 2002 Aug;88(8):715-23. Epub 2002 Jun 4.
High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.	['Kocken CH', 'Withers-Martinez C', 'Dubbeld MA', 'van der Wel A', 'Hackett F', 'Valderrama A', 'Blackman MJ', 'Thomas AW']	Infect Immun. 2002 Aug;70(8):4471-6.
Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.	['Rogers WO', 'Weiss WR', 'Kumar A', 'Aguiar JC', 'Tine JA', 'Gwadz R', 'Harre JG', 'Gowda K', 'Rathore D', 'Kumar S', 'Hoffman SL']	Infect Immun. 2002 Aug;70(8):4329-35.
Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria.	['Arevalo-Herrera M', 'Valencia AZ', 'Vergara J', 'Bonelo A', 'Fleischhauer K', 'Gonzalez JM', 'Restrepo JC', 'Lopez JA', 'Valmori D', 'Corradin G', 'Herrera S']	Parasite Immunol. 2002 Mar;24(3):161-9.
Vaccines against asexual stage malaria parasites.	['Kumar S', 'Epstein JE', 'Richie TL']	Chem Immunol. 2002;80:262-86.
Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.	['Ballou WR', 'Kester KE', 'Heppner DG']	Chem Immunol. 2002;80:253-61.
In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.	['Pang AL', 'Hashimoto CN', 'Tam LQ', 'Meng ZQ', 'Hui GS', 'Ho WK']	Infect Immun. 2002 Jun;70(6):2772-9.
Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines.	['Silvie O', 'Semblat JP', 'Franetich JF', 'Hannoun L', 'Eling W', 'Mazier D']	Parasite Immunol. 2002 Apr;24(4):221-3.
Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.	['Singh AP', 'Puri SK', 'Chitnis CE']	Mol Biochem Parasitol. 2002 Apr 30;121(1):21-31.
Malaria research: host-parasite interactions and new developments in chemotherapy, immunology and vaccinology.	['Perlmann P', 'Bjorkman A']	Curr Opin Infect Dis. 2000 Oct;13(5):431-443.
Truncation of merozoite surface protein 3 disrupts its trafficking and that of acidic-basic repeat protein to the surface of Plasmodium falciparum merozoites.	['Mills KE', 'Pearce JA', 'Crabb BS', 'Cowman AF']	Mol Microbiol. 2002 Mar;43(6):1401-11.
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.	['Hoffman SL', 'Goh LM', 'Luke TC', 'Schneider I', 'Le TP', 'Doolan DL', 'Sacci J', 'de la Vega P', 'Dowler M', 'Paul C', 'Gordon DM', 'Stoute JA', 'Church LW', 'Sedegah M', 'Heppner DG', 'Ballou WR', 'Richie TL']	J Infect Dis. 2002 Apr 15;185(8):1155-64. Epub 2002 Apr 1.
Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris.	['Soares IS', 'Rodrigues MM']	Parasitology. 2002 Mar;124(Pt 3):237-46.
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.	['Genton B', 'Betuela I', 'Felger I', 'Al-Yaman F', 'Anders RF', 'Saul A', 'Rare L', 'Baisor M', 'Lorry K', 'Brown GV', 'Pye D', 'Irving DO', 'Smith TA', 'Beck HP', 'Alpers MP']	J Infect Dis. 2002 Mar 15;185(6):820-7. Epub 2002 Feb 14.
CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas.	['Allsopp CE', 'Sanni LA', 'Reubsaet L', 'Ndungu F', 'Newbold C', 'Mwangi T', 'Marsh K', 'Langhorne J']	J Infect Dis. 2002 Mar 15;185(6):812-9. Epub 2002 Feb 28.
Towards a blood-stage vaccine for malaria: are we following all the leads?	['Good MF']	Nat Rev Immunol. 2001 Nov;1(2):117-25.
DNA vaccine against malaria: a long way to go.	['Tuteja R']	Crit Rev Biochem Mol Biol. 2002;37(1):29-54.
The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite.	['Black CG', 'Barnwell JW', 'Huber CS', 'Galinski MR', 'Coppel RL']	Mol Biochem Parasitol. 2002 Apr 9;120(2):215-24.
Characterization of proteases involved in the processing of Plasmodium falciparum serine repeat antigen (SERA).	['Li J', 'Matsuoka H', 'Mitamura T', 'Horii T']	Mol Biochem Parasitol. 2002 Apr 9;120(2):177-86.
Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.	['Cowman AF', 'Baldi DL', 'Duraisingh M', 'Healer J', 'Mills KE', "O'Donnell RA", 'Thompson J', 'Triglia T', 'Wickham ME', 'Crabb BS']	Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):25-33.
Effects of DNA vaccine in murine malaria using a full-length cDNA library.	['Shibui A', 'Ohmori Y', 'Suzuki Y', 'Sasaki M', 'Nogami S', 'Sugano S', 'Watanabe J']	Res Commun Mol Pathol Pharmacol. 2001 Mar-Apr;109(3-4):147-57.
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.	['Bojang KA', 'Milligan PJ', 'Pinder M', 'Vigneron L', 'Alloueche A', 'Kester KE', 'Ballou WR', 'Conway DJ', 'Reece WH', 'Gothard P', 'Yamuah L', 'Delchambre M', 'Voss G', 'Greenwood BM', 'Hill A', 'McAdam KP', 'Tornieporth N', 'Cohen JD', 'Doherty T']	Lancet. 2001 Dec 8;358(9297):1927-34.
Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites.	['Tsuji M', 'Zavala F']	Mol Immunol. 2001 Dec;38(6):433-42.
Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.	['Milich DR', 'Hughes J', 'Jones J', 'Sallberg M', 'Phillips TR']	Vaccine. 2001 Dec 12;20(5-6):771-88.
Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy.	['Witney AA', 'Doolan DL', 'Anthony RM', 'Weiss WR', 'Hoffman SL', 'Carucci DJ']	Mol Biochem Parasitol. 2001 Dec;118(2):233-45.
Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.	['Coley AM', 'Campanale NV', 'Casey JL', 'Hodder AN', 'Crewther PE', 'Anders RF', 'Tilley LM', 'Foley M']	Protein Eng. 2001 Sep;14(9):691-8.
Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments.	['Cavinato RA', 'Bastos KR', 'Sardinha LR', 'Elias RM', 'Alvarez JM', "d'Imperio Lima MR"]	Parasite Immunol. 2001 Nov;23(11):587-97.
Variant proteins on the surface of malaria-infected erythrocytes--developing vaccines.	'Duffy PE', 'Craig AG', 'Baruch DI'	Trends Parasitol. 2001 Aug;17(8):354-6.
Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors.	'Cunha MG', 'Rodrigues MM', 'Soares IS'	Vaccine. 2001 Nov 12;20(3-4):385-96.
Biomedicine. Turncoat antibodies.	['Duffy PE', 'Fried M']	Science. 2001 Sep 14;293(5537):2009-10.
An analysis of haematological parameters in patients and individual residents of a Plasmodium falciparum malaria holoendemic area of western Kenya.	'Orago AS', 'Wattimah DN', 'Aloka PL', 'Gitau CW', 'Orago MA', 'Onyango TG'	Microbios. 2001;106 Suppl 2:117-32.
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.	'Schneider J', 'Langermans JA', 'Gilbert SC', 'Blanchard TJ', 'Twigg S', 'Naitza S', 'Hannan CM', 'Aidoo M', 'Crisanti A', 'Robson KJ', 'Smith GL', 'Hill AV', 'Thomas AW'	Vaccine. 2001 Sep 14;19(32):4595-602.
Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?	'Stowers AW', 'Miller LH'	Trends Parasitol. 2001 Sep;17(9):415-9.
Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum.	'Gruner AC', 'Brahimi K', 'Letourneur F', 'Renia L', 'Eling W', 'Snounou G', 'Druilhe P'	J Infect Dis. 2001 Oct 1;184(7):892-7. Epub 2001 Aug 17.
Malaria: a vaccine concept based on sickle haemoglobin's augmentation of an innate autoimmune process to band 3.	'Kennedy JR'	Int J Parasitol. 2001 Sep;31(11):1275-7.
Exploring the transcriptome of the malaria sporozoite stage.	'Kappe SH', 'Gardner MJ', 'Brown SM', 'Ross J', 'Matuschewski K', 'Ribeiro JM', 'Adams JH', 'Quackenbush J', 'Cho J', 'Carucci DJ', 'Hoffman SL', 'Nussenzweig V'	Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9895-900. Epub 2001 Aug 7.
Immunogenicity of recombinant fragments of Plasmodium falciparum acidic basic repeat antigen produced in Escherichia coli.	'Kushwaha A', 'Rao PP', 'Suresh RP', 'Chauhan VS'	Parasite Immunol. 2001 Aug;23(8):435-44.
Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen.	'Heal KG', 'Sheikh NA', 'Hollingdale MR', 'Morrow WJ', 'Taylor-Robinson AW'	Vaccine. 2001 Jul 20;19(30):4153-61.
Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.	'Tsuji M', 'Rodrigues EG', 'Nussenzweig S'	Biol Chem. 2001 Apr;382(4):553-70.
Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.	'Sanchez GI', 'Sedegah M', 'Rogers WO', 'Jones TR', 'Sacci J', 'Witney A', 'Carucci DJ', 'Kumar N', 'Hoffman SL'	Infect Immun. 2001 Jun;69(6):3897-905.
Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.	'Kurtis JD', 'Hollingdale MR', 'Luty AJ', 'Lanar DE', 'Krzych U', 'Duffy PE'	Trends Parasitol. 2001 May;17(5):219-23.
Variant antigens of Plasmodium falciparum encoded by the var multigenic family are multifunctional macromolecules.	'Nogueira PA', 'Wunderlich G', 'Pereira da Silva LH'	Res Microbiol. 2001 Mar;152(2):141-7.
Gene targeting in the rodent malaria parasite Plasmodium yoelii.	'Mota MM', 'Thathy V', 'Nussenzweig RS', 'Nussenzweig V'	Mol Biochem Parasitol. 2001 Apr 6;113(2):271-8.
Specificity of the protective antibody response to apical membrane antigen 1.	'Hodder AN', 'Crewther PE', 'Anders RF'	Infect Immun. 2001 May;69(5):3286-94.
Parasite variation provides hope for malaria vaccine design.	'Taylor-Robinson A'	Trends Microbiol. 2001 Apr;9(4):157-8.
Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview.	'Oliveira-Ferreira J', 'Daniel-Ribeiro C'	Mem Inst Oswaldo Cruz. 2001 Feb;96(2):221-7.
Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.	'Singh S', 'Pandey K', 'Chattopadhayay R', 'Yazdani SS', 'Lynn A', 'Bharadwaj A', 'Ranjan A', 'Chitnis C'	J Biol Chem. 2001 May 18;276(20):17111-6. Epub 2001 Mar 13.
Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.	'Mota MM', 'Brown KN', 'Do Rosario VE', 'Holder AA', 'Jarra W'	Infect Immun. 2001 Apr;69(4):2535-41.
The Plasmodium falciparum knob-associated PfEMP3 antigen is also expressed at pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion.	'Gruner AC', 'Brahimi K', 'Eling W', 'Konings R', 'Meis J', 'Aikawa M', 'Daubersies P', 'Guerin-Marchand C', 'Mellouk S', 'Snounou G', 'Druilhe P'	Mol Biochem Parasitol. 2001 Feb;112(2):253-61.
Vaccines. Searching for a parasite's weak spot.	'Taubes G'	Science. 2000 Oct 20;290(5491):434-7.
The erythrocyte binding motif of plasmodium vivax duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea.	'Xainli J', 'Adams JH', 'King CL'	Mol Biochem Parasitol. 2000 Dec;111(2):253-60.
Inducing protective antibodies against ring-infected erythrocyte surface peptide antigen of Plasmodium falciparum using immunostimulating complex (ISCOMs) delivery.	'Chopra N', 'Biswas S', 'Thomas B', 'Sabhnani L', 'Rao DN'	Med Microbiol Immunol (Berl). 2000 Nov;189(2):75-83.
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.	'Daubersies P', 'Thomas AW', 'Millet P', 'Brahimi K', 'Langermans JA', 'Ollomo B', 'BenMohamed L', 'Slierendregt B', 'Eling W', 'Van Belkum A', 'Dubreuil G', 'Meis JF', 'Guerin-Marchand C', 'Cayphas S', 'Cohen J', 'Gras-Masse H', 'Druilhe P'	Nat Med. 2000 Nov;6(11):1258-63.
Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization.	'Bolad A', 'Berzins K'	Scand J Immunol. 2000 Sep;52(3):233-9.
Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas.	'Ravichandran M', 'Doolan DL', 'Cox-Singh J', 'Hoffman SL', 'Singh B'	Parasite Immunol. 2000 Sep;22(9):469-73.
Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates.	'Gutierrez A', 'Vicini J', 'Patarroyo ME', 'Murillo LA', 'Patarroyo MA'	Exp Parasitol. 2000 Jul;95(3):215-9.
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion.	'Kocken CH', 'Narum1 DL', 'Massougbodji A', 'Ayivi B', 'Dubbeld MA', 'van der Wel A', 'Conway DJ', 'Sanni A', 'Thomas AW'	Mol Biochem Parasitol. 2000 Jul;109(2):147-56.
Erythrocyte adhesion to vascular endothelium: clinical applications.	'Chaudet B', 'Renard M', 'Seigneur M', 'Boisseau MR'	Rev Med Interne. 2000 Jul;21(7):599-607.
Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A.	'Duffy PE', 'Fried M'	Biochem Soc Trans. 1999 Aug;27(4):478-82.
The complexity of protective immunity against liver-stage malaria.	'Doolan DL', 'Hoffman SL'	J Immunol. 2000 Aug 1;165(3):1453-62.
The immunology of malaria infection.	'Plebanski M', 'Hill AV'	Curr Opin Immunol. 2000 Aug;12(4):437-41.
HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.	'Doolan DL', 'Southwood S', 'Chesnut R', 'Appella E', 'Gomez E', 'Richards A', 'Higashimoto YI', 'Maewal A', 'Sidney J', 'Gramzinski RA', 'Mason C', 'Koech D', 'Hoffman SL', 'Sette A'	J Immunol. 2000 Jul 15;165(2):1123-37.
Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells.	'Cowman AF', 'Baldi DL', 'Healer J', 'Mills KE', "O'Donnell RA", 'Reed MB', 'Triglia T', 'Wickham ME', 'Crabb BS'	FEBS Lett. 2000 Jun 30;476(1-2):84-8.
A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein.	'Liang H', 'Narum DL', 'Fuhrmann SR', 'Luu T', 'Sim BK'	Infect Immun. 2000 Jun;68(6):3564-8.
Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.	'Michon P', 'Fraser T', 'Adams JH'	Infect Immun. 2000 Jun;68(6):3164-71.
Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro.	'Nikodem D', 'Davidson E'	Mol Biochem Parasitol. 2000 Apr 30;108(1):79-91.
gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites.	'McKenna KC', 'Tsuji M', 'Sarzotti M', 'Sacci JB Jr', 'Witney AA', 'Azad AF'	Infect Immun. 2000 Apr;68(4):2224-30.
Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids.	'Narum DL', 'Haynes JD', 'Fuhrmann S', 'Moch K', 'Liang H', 'Hoffman SL', 'Sim BK'	Infect Immun. 2000 Apr;68(4):1964-6.
Vaccine efficacy, and immunity affecting transmission.	'Targett G'	Parassitologia. 1999 Sep;41(1-3):433-6.
Malaria vaccines: triumphs or tribulations?	'Ballou WR', 'Kester KE', 'Stoute JA', 'Heppner DG'	Parassitologia. 1999 Sep;41(1-3):403-8.
Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.	'Nardin E', 'Zavala F', 'Nussenzweig V', 'Nussenzweig RS'	Parassitologia. 1999 Sep;41(1-3):397-402.
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.	'Doherty JF', 'Pinder M', 'Tornieporth N', 'Carton C', 'Vigneron L', 'Milligan P', 'Ballou WR', 'Holland CA', 'Kester KE', 'Voss G', 'Momin P', 'Greenwood BM', 'McAdam KP', 'Cohen J'	Am J Trop Med Hyg. 1999 Dec;61(6):865-8.
Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.	"O'Donnell RA", 'Saul A', 'Cowman AF', 'Crabb BS'	Nat Med. 2000 Jan;6(1):91-5.
Adherence of Plasmodium falciparum-infected erythrocytes to chondroitin 4-sulfate.	'Gowda DC', 'Ockenhouse CF'	Biosci Rep. 1999 Aug;19(4):261-71.
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.	'Charoenvit Y', 'Majam VF', 'Corradin G', 'Sacci JB Jr', 'Wang R', 'Doolan DL', 'Jones TR', 'Abot E', 'Patarroyo ME', 'Guzman F', 'Hoffman SL'	Infect Immun. 1999 Nov;67(11):5604-14.
Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A.	'Okoyeh JN', 'Pillai CR', 'Chitnis CE'	Infect Immun. 1999 Nov;67(11):5784-91.
Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens.	'Rogers WO', 'Gowda K', 'Hoffman SL'	Vaccine. 1999 Aug 6;17(23-24):3136-44.
Immune effector mechanisms in malaria.	'Good MF', 'Doolan DL'	Curr Opin Immunol. 1999 Aug;11(4):412-9.
Susceptibility of Panamanian Aotus lemurinus lemurinus to sporozoite-induced Plasmodium falciparum (Santa Lucia) infection.	'Gramzinski RA', 'Obaldia N 3rd', 'Jones TR', 'Rossan RN', 'Collins WE', 'Garrett DO', 'Lal AA', 'Hoffman SL'	Am J Trop Med Hyg. 1999 Jul;61(1):19-25.
Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites.	'Ramasamy R', 'Yasawardena S', 'Kanagaratnam R', 'Buratti E', 'Baralle FE', 'Ramasamy MS'	Parasite Immunol. 1999 Aug;21(8):397-407.
Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans.	'Flanagan KL', 'Plebanski M', 'Akinwunmi P', 'Lee EA', 'Reece WH', 'Robson KJ', 'Hill AV', 'Pinder M'	Eur J Immunol. 1999 Jun;29(6):1943-54.
Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.	'Somner EA', 'Ogun SA', 'Sinha KA', 'Spencer Valero LM', 'Lee JJ', 'Harrison JA', 'Holder AA', 'Hormaeche CE', 'Khan CM'	Microbiology. 1999 Jan;145 ( Pt 1):221-9.
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.	'Shi YP', 'Hasnain SE', 'Sacci JB', 'Holloway BP', 'Fujioka H', 'Kumar N', 'Wohlhueter R', 'Hoffman SL', 'Collins WE', 'Lal AA'	Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1615-20.
Reduced amide pseudopeptide analogues of a malaria peptide possess secondary structural elements responsible for induction of functional antibodies which react with native proteins expressed in Plasmodium falciparum erythrocyte stages.	'Lozano JM', 'Espejo F', 'Diaz D', 'Salazar LM', 'Rodriguez J', 'Pinzon C', 'Calvo JC', 'Guzman F', 'Patarroyo ME'	J Pept Res. 1998 Dec;52(6):457-69.
Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.	'Rotman HL', 'Daly TM', 'Long CA'	Exp Parasitol. 1999 Jan;91(1):78-85.
Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes.	'Burns JM Jr', 'Adeeku EK', 'Dunn PD'	Infect Immun. 1999 Feb;67(2):675-80.
In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.	'Hedstrom RC', 'Doolan DL', 'Wang R', 'Kumar A', 'Sacci JB Jr', 'Gardner MJ', 'Aguiar JC', 'Charoenvit Y', 'Sedegah M', 'Tine JA', 'Margalith M', 'Hobart P', 'Hoffman SL'	Int J Mol Med. 1998 Jul;2(1):29-38.
Plasmodium falciparum and chondroitin-4-sulfate: the new key couple in sequestration.	'Pouvelle B', 'Fusai T', 'Gysin J'	Med Trop (Mars). 1998;58(2):187-98.
Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.	'Kang Y', 'Calvo PA', 'Daly TM', 'Long CA'	J Immunol. 1998 Oct 15;161(8):4211-9.
Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.	'Matsumoto S', 'Yukitake H', 'Kanbara H', 'Yamada T'	J Exp Med. 1998 Sep 7;188(5):845-54.
Vaccination trials and immune response against Plasmodium falciparum in Saimiri monkeys.	'Perraut R', 'Gerraud O'	Med Trop (Mars). 1998;58(1):76-84.
Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.	'Jakobsen PH', 'Heegaard PM', 'Koch C', 'Wasniowska K', 'Lemnge MM', 'Jensen JB', 'Sim BK'	Infect Immun. 1998 Sep;66(9):4203-7.
Biology of malarial liver stages: implications for vaccine design.	'Hollingdale MR', 'McCormick CJ', 'Heal KG', 'Taylor-Robinson AW', 'Reeve P', 'Boykins R', 'Kazura JW'	Ann Trop Med Parasitol. 1998 Jun;92(4):411-7.
Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA).	'Pang XL', 'Horii T'	Vaccine. 1998 Aug;16(13):1299-305.
Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.	'Perlaza BL', 'Arevalo-Herrera M', 'Brahimi K', 'Quintero G', 'Palomino JC', 'Gras-Masse H', 'Tartar A', 'Druilhe P', 'Herrera S'	Infect Immun. 1998 Jul;66(7):3423-8.
Pathways and strategies for developing a malaria blood-stage vaccine.	'Good MF', 'Kaslow DC', 'Miller LH'	Annu Rev Immunol. 1998;16:57-87.
Research toward vaccines against malaria.	'Miller LH', 'Hoffman SL'	Nat Med. 1998 May;4(5 Suppl):520-4.
Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.	'Nardin EH', 'Calvo-Calle JM', 'Oliveira GA', 'Clavijo P', 'Nussenzweig R', 'Simon R', 'Zeng W', 'Rose K'	Vaccine. 1998 Apr;16(6):590-600.
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.	'Schneider J', 'Gilbert SC', 'Blanchard TJ', 'Hanke T', 'Robson KJ', 'Hannan CM', 'Becker M', 'Sinden R', 'Smith GL', 'Hill AV'	Nat Med. 1998 Apr;4(4):397-402.
Non-detergent sulphobetaines enhance the recovery of membrane and/or cytoskeleton-associated proteins and active proteases from erythrocytes infected by Plasmodium falciparum.	'Blisnick T', 'Morales-Betoulle ME', 'Vuillard L', 'Rabilloud T', 'Braun Breton C'	Eur J Biochem. 1998 Mar 15;252(3):537-41.
Evaluation of SPf66 malaria vaccine efficacy in Brazil.	'Urdaneta M', 'Prata A', 'Struchiner CJ', 'Tosta CE', 'Tauil P', 'Boulos M'	Am J Trop Med Hyg. 1998 Mar;58(3):378-85.
Malaria: recent immunological acquisitions and therapeutic prospects.	'Leri O', 'Perinelli P', 'Losi T', 'Mastropasqua M', 'Peri C', 'Tubili S'	Clin Ter. 1997 Dec;148(12):655-65.
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.	'Bull PC', 'Lowe BS', 'Kortok M', 'Molyneux CS', 'Newbold CI', 'Marsh K'	Nat Med. 1998 Mar;4(3):358-60.
Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.	'Guevara Patino JA', 'Holder AA', 'McBride JS', 'Blackman MJ'	J Exp Med. 1997 Nov 17;186(10):1689-99.
T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.	'Connelly M', 'King CL', 'Bucci K', 'Walters S', 'Genton B', 'Alpers MP', 'Hollingdale M', 'Kazura JW'	Infect Immun. 1997 Dec;65(12):5082-7.
Continuous culture of Plasmodium falciparum: its impact on malaria research.	'Trager W', 'Jensen JB'	Int J Parasitol. 1997 Sep;27(9):989-1006.
Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections.	'Doolan DL', 'Hoffman SL'	Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1361-7.
Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence.	'Baruch DI', 'Ma XC', 'Singh HB', 'Bi X', 'Pasloske BL', 'Howard RJ'	Blood. 1997 Nov 1;90(9):3766-75.
Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.	'Bergmann ES', 'Ballou RW', 'Krzych U'	Cell Immunol. 1997 Sep 15;180(2):143-52.
Protein particle vaccines against malaria.	'Gilbert SC', 'Hill AV'	Parasitol Today. 1997 Aug;13(8):302-6.
Designing a malaria vaccine.	'Targett GA'	J Clin Pathol. 1997 Jul;50(7):535-6.
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.	'Hoffman SL', 'Doolan DL', 'Sedegah M', 'Aguiar JC', 'Wang R', 'Malik A', 'Gramzinski RA', 'Weiss WR', 'Hobart P', 'Norman JA', 'Margalith M', 'Hedstrom RC'	Vaccine. 1997 Jun;15(8):842-5.
Multi-gene vaccination against malaria: A multistage, multi-immune response approach.	'Doolan DL', 'Hoffman SL'	Parasitol Today. 1997 May;13(5):171-8.
Vaccines: a roller-coaster of hopes.	'Butler D', 'Maurice J', "O'Brien C"	Nature. 1997 Apr 10;386(6625):537-8.
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.	'Yang C', 'Collins WE', 'Xiao L', 'Saekhou AM', 'Reed RC', 'Nelson CO', 'Hunter RL', 'Jue DL', 'Fang S', 'Wohlhueter RM', 'Udhayakumar V', 'Lal AA'	Vaccine. 1997 Mar;15(4):377-86.
Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity.	'Renggli J', 'Hahne M', 'Matile H', 'Betschart B', 'Tschopp J', 'Corradin G'	Parasite Immunol. 1997 Mar;19(3):145-8.
Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes.	'Rogerson SJ', 'Brown GV'	Parasitol Today. 1997 Feb;13(2):70-5.
Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175.	'Liang H', 'Sim BK'	Mol Biochem Parasitol. 1997 Feb;84(2):241-5.
Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.	'Wiser MF', 'Giraldo LE', 'Schmitt-Wrede HP', 'Wunderlich F'	Exp Parasitol. 1997 Jan;85(1):43-54.
Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.	'Wang R', 'Charoenvit Y', 'Daly TM', 'Long CA', 'Corradin G', 'Hoffman SL'	Immunol Lett. 1996 Nov;53(2-3):83-93.
Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells.	'Urquiza M', 'Rodriguez LE', 'Suarez JE', 'Guzman F', 'Ocampo M', 'Curtidor H', 'Segura C', 'Trujillo E', 'Patarroyo ME'	Parasite Immunol. 1996 Oct;18(10):515-26.
An efficacy trial of a malaria vaccine in Gambian infants and comparison with insecticide-treated bednets.	"D'Alessandro U"	Ann Trop Med Parasitol. 1996 Aug;90(4):373-8.
The development of malaria vaccines: SPf66--what next?	'Tanner M', 'Alonso PL'	Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1210-5.
Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates.	'Ampudia E', 'Patarroyo MA', 'Patarroyo ME', 'Murillo LA'	Mol Biochem Parasitol. 1996 Jun;78(1-2):269-72.
MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.	'White KL', 'Snyder HL', 'Krzych U'	J Immunol. 1996 May 1;156(9):3374-81.
Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania.	'Lalvani A', 'Hurt N', 'Aidoo M', 'Kibatala P', 'Tanner M', 'Hill AV'	Eur J Immunol. 1996 Apr;26(4):773-9.
Observations on the biological nature of Plasmodium vivax sporozoites.	'Collins WE', 'Sullivan JS', 'Morris CL', 'Galland GG', 'Richardson BB'	J Parasitol. 1996 Apr;82(2):216-9.
Ultrastructural aspects of Plasmodium falciparum-infected erythrocyte adherence to endothelial cells of Saimiri brain microvasculature.	'Robert C', 'Peyrol S', 'Pouvelle B', 'Gay-Andrieu F', 'Gysin J'	Am J Trop Med Hyg. 1996 Feb;54(2):169-77.
Malaria in children.	'Steele RW'	Adv Pediatr Infect Dis. 1996;12:325-49.
Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites.	'Chatterjee S', 'Francois G', 'Druilhe P', 'Timperman G', 'Wery M'	Parasitol Res. 1996;82(4):297-303.
Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.	'Calvo PA', 'Daly TM', 'Long CA'	Exp Parasitol. 1996 Jan;82(1):54-64.
Immunogenicity of recombinant Plasmodium falciparum rhoptry associated proteins 1 and 2.	'Stowers A', 'Prescott N', 'Cooper J', 'Takacs B', 'Stueber D', 'Kennedy P', 'Saul A'	Parasite Immunol. 1995 Dec;17(12):631-42.
T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens.	'Krzych U', 'Lyon JA', 'Jareed T', 'Schneider I', 'Hollingdale MR', 'Gordon DM', 'Ballou WR'	J Immunol. 1995 Oct 15;155(8):4072-7.
Efficacy trial of malaria vaccine SPf66 in Gambian infants.	"D'Alessandro U", 'Leach A', 'Drakeley CJ', 'Bennett S', 'Olaleye BO', 'Fegan GW', 'Jawara M', 'Langerock P', 'George MO', 'Targett GA', 'et al.'	Lancet. 1995 Aug 19;346(8973):462-7.
Isolation and characterization of brain microvascular endothelial cells from Saimiri monkeys. An in vitro model for sequestration of Plasmodium falciparum-infected erythrocytes.	'Gay F', 'Robert C', 'Pouvelle B', 'Peyrol S', 'Scherf A', 'Gysin J'	J Immunol Methods. 1995 Jul 17;184(1):15-28.
HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.	'Wizel B', 'Houghten R', 'Church P', 'Tine JA', 'Lanar DE', 'Gordon DM', 'Ballou WR', 'Sette A', 'Hoffman SL'	J Immunol. 1995 Jul 15;155(2):766-75.
Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.	'Kang Y', 'Long CA'	Mol Biochem Parasitol. 1995 Jul;73(1-2):103-10.
Stable transfection of malaria parasite blood stages.	'van Dijk MR', 'Waters AP', 'Janse CJ'	Science. 1995 Jun 2;268(5215):1358-62.
Development of vaccines based on formulations containing nonionic block copolymers.	'Brey RN'	Pharm Biotechnol. 1995;6:297-311.
Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.	'Rodrigues M', 'Li S', 'Murata K', 'Rodriguez D', 'Rodriguez JR', 'Bacik I', 'Bennink JR', 'Yewdell JW', 'Garcia-Sastre A', 'Nussenzweig RS', 'et al.'	J Immunol. 1994 Nov 15;153(10):4636-48.
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.	'Narum DL', 'Thomas AW'	Mol Biochem Parasitol. 1994 Sep;67(1):59-68.
Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion.	'Chitnis CE', 'Miller LH'	J Exp Med. 1994 Aug 1;180(2):497-506.
Inducing protective immune responses against the sporozoite and liver stages of Plasmodium.	'Hoffman SL', 'Franke ED'	Immunol Lett. 1994 Jul;41(2-3):89-94.
Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage.	'Renia L', 'Rodrigues MM', 'Nussenzweig V'	Immunology. 1994 May;82(1):164-8.
Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP.	'Fidock DA', 'Bottius E', 'Brahimi K', 'Moelans II', 'Aikawa M', 'Konings RN', 'Certa U', 'Olafsson P', 'Kaidoh T', 'Asavanich A', 'et al.'	Mol Biochem Parasitol. 1994 Apr;64(2):219-32.
Laboratory methods for the conduct of experimental malaria challenge of volunteers.	'Davis JR'	Vaccine. 1994 Mar;12(4):321-7.
Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.	'Kabilan L', 'Sharma VP', 'Kaur P', 'Ghosh SK', 'Yadav RS', 'Chauhan VS'	Infect Immun. 1994 Feb;62(2):685-91.
Malaria, the red cell, and the endothelium.	'Pasloske BL', 'Howard RJ'	Annu Rev Med. 1994;45:283-95.
Clinical trials of Plasmodium falciparum erythrocytic stage vaccines.	'Ballou WP'	Am J Trop Med Hyg. 1994;50(4 Suppl):59-65.
Immunity to erythrocytic stages of malarial parasites.	'Long CA', 'Daly TM', 'Kima P', 'Srivastava I'	Am J Trop Med Hyg. 1994;50(4 Suppl):27-32.
Chimpanzees and supporting models in the study of malaria pre-erythrocytic stages.	'Thomas AW', 'Slierendregt B', 'Mons B', 'Druilhe P'	Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:111-4.
T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).	'Lucas B', 'Engels A', 'Camus D', 'Haque A'	Infect Immun. 1993 Nov;61(11):4863-9.
The role of CD4+ T cells in immunity to malaria sporozoites.	'Weiss WR', 'Sedegah M', 'Berzofsky JA', 'Hoffman SL'	J Immunol. 1993 Sep 1;151(5):2690-8.
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.	'Egan JE', 'Hoffman SL', 'Haynes JD', 'Sadoff JC', 'Schneider I', 'Grau GE', 'Hollingdale MR', 'Ballou WR', 'Gordon DM'	Am J Trop Med Hyg. 1993 Aug;49(2):166-73.
Transmission-blocking immunity against malaria and other vector-borne diseases.	'Kaslow DC'	Curr Opin Immunol. 1993 Aug;5(4):557-65.
Immunity to blood stages of malaria.	'Long CA'	Curr Opin Immunol. 1993 Aug;5(4):548-56.
Plasmodium vivax:recombination between potential allelic types of the merozoite surface protein MSP1 in parasites isolated from patients.	'Premawansa S', 'Snewin VA', 'Khouri E', 'Mendis KN', 'David PH'	Exp Parasitol. 1993 Mar;76(2):192-9.
Antigenic variants of Plasmodium chabaudi chabaudi AS and the effects of mosquito transmission.	'Brannan LR', 'McLean SA', 'Phillips RS'	Parasite Immunol. 1993 Mar;15(3):135-41.
Towards a vaccine against malaria.	'McGregor IA'	Br J Biomed Sci. 1993 Mar;50(1):35-42.
T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.	'Nardin EH', 'Nussenzweig RS'	Annu Rev Immunol. 1993;11:687-727.
Testosterone impairs efficacy of protective vaccination against P. chabaudi malaria.	'Wunderlich F', 'Maurin W', 'Benten WP', 'Schmitt-Wrede HP'	Vaccine. 1993;11(11):1097-9.
Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic or seasonal malaria.	'Saul A'	Acta Trop. 1993 Jan;52(4):283-96.
Molecular analysis of the association of HLA-B53 and resistance to severe malaria.	'Hill AV', 'Elvin J', 'Willis AC', 'Aidoo M', 'Allsopp CE', 'Gotch FM', 'Gao XM', 'Takiguchi M', 'Greenwood BM', 'Townsend AR', 'et al.'	Nature. 1992 Dec 3;360(6403):434-9.
Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.	'Behr C', 'Sarthou JL', 'Rogier C', 'Trape JF', 'Dat MH', 'Michel JC', 'Aribot G', 'Dieye A', 'Claverie JM', 'Druihle P', 'et al.'	J Immunol. 1992 Nov 15;149(10):3321-30.
Plasmodium falciparum-infected erythrocyte receptor(s) for CD36 and thrombospondin are restricted to knobs on the erythrocyte surface.	'Nakamura K', 'Hasler T', 'Morehead K', 'Howard RJ', 'Aikawa M'	J Histochem Cytochem. 1992 Sep;40(9):1419-22.
Vaccine strategies for malaria: applicability in areas of seasonal or epidemic malaria.	'Saul AJ'	Southeast Asian J Trop Med Public Health. 1992 Sep;23 Suppl 4:89-92.
Malaria: becoming more specific about non-specific immunity.	'Kwiatkowski D'	Curr Opin Immunol. 1992 Aug;4(4):425-31.
Antigenic diversity amongst ten geographic isolates of Plasmodium falciparum defined by merozoite invasion inhibition assay.	'Bhatia A', 'Vernes A'	Indian J Malariol. 1992 Mar;29(1):23-8.
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.	'Nardin E', 'Munesinghe YD', 'Moreno A', 'Clavijo P', 'Calle MC', 'Edelman R', 'Davis J', 'Herrington D', 'Nussenzweig RS'	Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:223-7.
Characterization of a surface antigen of Plasmodium falciparum merozoite with monoclonal antibody.	'Jiang CL', 'Guan WB', 'Kong XT', 'Wang XL', 'Yan YB'	Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992;10(3):184-6.
Towards a malaria vaccine: what is in sight?	'del Giudice G'	Allergol Immunopathol (Madr). 1991 May-Jun;19(3):129-35.
Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies.	'Ockenhouse CF', 'Klotz FW', 'Tandon NN', 'Jamieson GA'	Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3175-9.
Lack of correlation between red cell invasion by merozoites and anti-heat shock protein-70 antibody levels in malaria patients' sera.	'Biswas S', 'Sharma YD'	Int J Parasitol. 1991 Apr;21(2):213-7.
Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents.	'Barr PJ', 'Inselburg J', 'Green KM', 'Kansopon J', 'Hahm BK', 'Gibson HL', 'Lee-Ng CT', 'Bzik DJ', 'Li WB', 'Bathurst IC'	Mol Biochem Parasitol. 1991 Mar;45(1):159-70.
Isolation and characterization of a soluble antigen complex of Plasmodium falciparum with pyrogenic properties.	'Jakobsen PH', 'Hviid L', 'Theander TG', 'Riley EM', 'Grellier P', 'Bruun LS', 'Dalsgaard K', 'Schrevel J', 'Jepsen S'	APMIS. 1991 Jan;99(1):21-9.
Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.	'Sim BK', 'Orlandi PA', 'Haynes JD', 'Klotz FW', 'Carter JM', 'Camus D', 'Zegans ME', 'Chulay JD'	J Cell Biol. 1990 Nov;111(5 Pt 1):1877-84.
A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium.	'Waters AP', 'Thomas AW', 'Deans JA', 'Mitchell GH', 'Hudson DE', 'Miller LH', 'McCutchan TF', 'Cohen S'	J Biol Chem. 1990 Oct 15;265(29):17974-9.
Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes.	'Hoffman SL', 'Weiss W', 'Mellouk S', 'Sedegah M'	Immunol Lett. 1990 Aug;25(1-3):33-8.
Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence.	'Howard RJ', 'Handunnetti SM', 'Hasler T', 'Gilladoga A', 'de Aguiar JC', 'Pasloske BL', 'Morehead K', 'Albrecht GR', 'van Schravendijk MR'	Am J Trop Med Hyg. 1990 Aug;43(2 Pt 2):15-29.
Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria.	'Goonewardene R', 'Carter R', 'Gamage CP', 'Del Giudice G', 'David PH', 'Howie S', 'Mendis KN'	Eur J Immunol. 1990 Jun;20(6):1387-91.
Malaria vaccines.	'Gordon DM'	Infect Dis Clin North Am. 1990 Jun;4(2):299-313.
Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum.	'Orlandi PA', 'Sim BK', 'Chulay JD', 'Haynes JD'	Mol Biochem Parasitol. 1990 May;40(2):285-94.
T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes.	'Hoffman SL', 'Isenbarger D', 'Long GW', 'Sedegah M', 'Szarfman A', 'Mellouk S', 'Ballou WR'	Bull World Health Organ. 1990;68 Suppl:132-7.
Merozoite selection of erythrocytes by age and the induction of protective immunity.	'Brown KN', 'Carlsson J', 'Jarra W'	Blood Cells. 1990;16(2-3):313-8.
Pre-erythrocytic stage malaria parasites: non-circumsporozoite protein antigens.	'Hollingdale MR', 'Aikawa M', 'Chen GX', 'Meis JF', 'Sakhuja K', 'Sina B', 'Zhu JD'	Bull World Health Organ. 1990;68 Suppl:178-80.
Malaria vaccine development: pre-erythrocytic stages. Proceedings of a conference. National Naval Medical Center, Bethesda, Maryland, USA, 12-15 April 1989.	[]	Bull World Health Organ. 1990;68 Suppl:1-196.
A CTL epitope on the circumsporozoite protein of P. yoelii.	'Weiss WR', 'Houghten RA', 'Good MF', 'Berzofsky JA', 'Miller LH', 'Hoffman SL'	Bull World Health Organ. 1990;68 Suppl:99-103.
Development of an asexual blood stage malaria vaccine.	'Moreno A', 'Patarroyo ME'	Blood. 1989 Aug 1;74(2):537-46.
Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes.	'Lyon JA', 'Thomas AW', 'Hall T', 'Chulay JD'	Mol Biochem Parasitol. 1989 Aug;36(1):77-85.
Pre-erythrocytic stage malaria vaccine development: current status and future prospects.	'Riley E'	Parasitol Today. 1989 Jul;5(7):202-3.
Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.	'Murphy JR', 'Baqar S', 'Davis JR', 'Herrington DA', 'Clyde DF'	J Clin Microbiol. 1989 Jul;27(7):1434-7.
Why do Plasmodium falciparumm-infected erythrocytes form spontaneous erythrocyte rosettes?	'Wahlgren M', 'Carlson J', 'Udomsangpetch R', 'Perlmann P'	Parasitol Today. 1989 Jun;5(6):183-5.
Non-linear phenomena in host-parasite interactions.	'Anderson RM', 'May RM', 'Gupta S'	Parasitology. 1989;99 Suppl:S59-79.
Development of asexual erythrocytic malaria vaccines.	'Chulay JD'	Prog Clin Biol Res. 1989;313:13-21.
Construction and screening of Plasmodium falciparum cDNA library.	'Cheng Q', 'Shen YF', 'Qiang BQ', 'Yu SH', 'Wu NH', 'Chen JF', 'Fan RG', 'Cheng XK', 'Li WL', 'Mao YH', 'et al.'	Chin J Biotechnol. 1989;5(2):65-71.
Plasmodium vivax: cloning and expression of a major blood-stage surface antigen.	'del Portillo HA', 'Gysin J', 'Mattei DM', 'Khouri E', 'Udagama PV', 'Mendis KN', 'David PH'	Exp Parasitol. 1988 Dec;67(2):346-53.
An immunogenic antigen of murine Plasmodium yoelii 17X associates with class I MHC glycoproteins.	'Mogil RJ', 'Patton CL', 'Green DR'	J Immunol. 1988 Jul 1;141(1):258-64.
Development of malaria vaccines.	'Perrin LH', 'Simitsek P', 'Srivastava I'	Trop Geogr Med. 1988 Jul;40(3):S6-21.
Vaccination against malaria: current status and perspectives.	'Dubois P', 'Pereira da Silva L'	Rev Prat. 1988 Jun 16;38(18):1173-7.
A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.	'Kaslow DC', 'Quakyi IA', 'Syin C', 'Raum MG', 'Keister DB', 'Coligan JE', 'McCutchan TF', 'Miller LH'	Nature. 1988 May 5;333(6168):74-6.
The main obstacle to a malaria vaccine: the malaria parasite.	'Miller LH', 'Good MF'	Vaccine. 1988 Apr;6(2):104-6.
The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.	'Burns JM Jr', 'Daly TM', 'Vaidya AB', 'Long CA'	Proc Natl Acad Sci U S A. 1988 Jan;85(2):602-6.
Advances in the development of a malaria vaccine.	'Pink JR', 'Sturchler D'	Dtsch Med Wochenschr. 1987 Dec 4;112(49):1910-4.
Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum.	'Chulay JD', 'Lyon JA', 'Haynes JD', 'Meierovics AI', 'Atkinson CT', 'Aikawa M'	J Immunol. 1987 Oct 15;139(8):2768-74.
Inhibitory, opsonic and cytotoxic activities of monoclonal antibodies against asexual erythrocytic stages of Plasmodium falciparum.	'Li JL', 'Li YJ'	Parasitology. 1987 Oct;95 ( Pt 2):229-40.
Invasion of mouse erythrocytes by the human malaria parasite, Plasmodium falciparum.	'Klotz FW', 'Chulay JD', 'Daniel W', 'Miller LH'	J Exp Med. 1987 Jun 1;165(6):1713-8.
Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).	'Webster HK', 'Boudreau EF', 'Pang LW', 'Permpanich B', 'Sookto P', 'Wirtz RA'	J Clin Microbiol. 1987 Jun;25(6):1002-8.
Malaria invasion of human erythrocytes.	'Hermentin P'	Parasitol Today. 1987 Feb;3(2):52-5.
Vaccination against malaria: recent advances and the problems of antigenic diversity and other parasite evasion mechanisms.	'Howard RJ'	Int J Parasitol. 1987 Feb;17(1):17-29.
Research toward malaria vaccines.	'Miller LH', 'Howard RJ', 'Carter R', 'Good MF', 'Nussenzweig V', 'Nussenzweig RS'	Science. 1986 Dec 12;234(4782):1349-56.
Plasmodium yoelii: induction of attenuated mutants by irradiation.	'Waki S', 'Yonome I', 'Suzuki M'	Exp Parasitol. 1986 Dec;62(3):316-21.
Induction of protective immunity to malaria.	'Anders RF', 'Brown GV', 'Coppel RL', 'Kemp DJ'	Lepr Rev. 1986 Dec;57 Suppl 2:245-53.
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.	'Collins WE', 'Anders RF', 'Pappaioanou M', 'Campbell GH', 'Brown GV', 'Kemp DJ', 'Coppel RL', 'Skinner JC', 'Andrysiak PM', 'Favaloro JM', 'et al.'	Nature. 1986 Sep 18-24;323(6085):259-62.
Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.	'Hoffman SL', 'Wistar R Jr', 'Ballou WR', 'Hollingdale MR', 'Wirtz RA', 'Schneider I', 'Marwoto HA', 'Hockmeyer WT'	N Engl J Med. 1986 Sep 4;315(10):601-6.
Membrane orientation and antigenic peptides of an immunoprotective 74 kDa Plasmodium knowlesi glycoprotein.	'Schmidt-Ullrich R', 'Wallach DF', 'Monroe MM'	Mol Biochem Parasitol. 1986 Jul;20(1):15-23.
Identification of a Plasmodium chabaudi antigen present in the membrane of ring stage infected erythrocytes.	'Gabriel JA', 'Holmquist G', 'Perlmann H', 'Berzins K', 'Wigzell H', 'Perlmann P'	Mol Biochem Parasitol. 1986 Jul;20(1):67-75.
The fight against malaria--chemotherapy and immunoprophylaxis. 2. Immunoprophylaxis.	'Wagner WH'	Arzneimittelforschung. 1986 Feb;36(2):163-75.
Malaria--yesterday, today, and tomorrow.	'Brown GV', 'Nossal GJ'	Perspect Biol Med. 1986 Autumn;30(1):65-76.
Invasion of erythrocytes by malaria parasites: a cellular and molecular overview.	'Hadley TJ'	Annu Rev Microbiol. 1986;40:451-77.
Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.	'Heidrich HG'	Z Parasitenkd. 1986;72(1):1-11.
Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity.	'Wahlgren M', 'Bjorkman A', 'Perlmann H', 'Berzins K', 'Perlmann P'	Am J Trop Med Hyg. 1986 Jan;35(1):22-9.
The Wellcome Trust lecture. Genes for antigens of Plasmodium falciparum.	'Kemp DJ', 'Coppel RL', 'Stahl HD', 'Bianco AE', 'Corcoran LM', 'McIntyre P', 'Langford CJ', 'Favaloro JM', 'Crewther PE', 'Brown GV', 'et al.'	Parasitology. 1986;92 Suppl:S83-108.
Immunity to an attenuated variant of Plasmodium berghei: role of some non-specific factors.	'Waki S', 'Nakazawa S', 'Taverne J', 'Targett GA', 'Playfair JH'	Parasitology. 1985 Oct;91 ( Pt 2):263-72.
Progress towards a malaria vaccine.	'Cohen S'	J R Coll Physicians Lond. 1985 Oct;19(4):210-3.
Isolation of the gene for a glycophorin-binding protein implicated in erythrocyte invasion by a malaria parasite.	'Ravetch JV', 'Kochan J', 'Perkins M'	Science. 1985 Mar 29;227(4694):1593-7.
Macrophages as effector cells in immunity to malaria.	'Playfair JH', 'Dockrell H', 'Taverne J'	Immunol Lett. 1985;11(3-4):233-7.
Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.	'Anders RF', 'Brown GV', 'Coppel RL', 'Stahl HD', 'Bianco AE', 'Favaloro JM', 'Crewther PE', 'Culvenor JG', 'Kemp DJ'	Dev Biol Stand. 1985;62:81-9.
Perspectives for malaria vaccination.	'Miller LH', 'David PH', 'Hadley TJ'	Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):99-115.
Receptors on red cells for Plasmodium falciparum and their interaction with merozoites.	'Pasvol G'	Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):189-200.
The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes.	'Thomas AW', 'Deans JA', 'Mitchell GH', 'Alderson T', 'Cohen S'	Mol Biochem Parasitol. 1984 Oct;13(2):187-99.
Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.	'Coppel RL', 'Cowman AF', 'Anders RF', 'Bianco AE', 'Saint RB', 'Lingelbach KR', 'Kemp DJ', 'Brown GV'	Nature. 1984 Aug 30-Sep 5;310(5980):789-92.
Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.	[]	Bull World Health Organ. 1984;62(5):715-27.
Malaria vaccine antigen(s): detergent solubilization, partial isolation, and recovery of immunoprotective activity.	"D'Antonio LE", 'Keshavarz-Valian H', 'Alger NE'	Infect Immun. 1984 Jan;43(1):442-4.
Malaria--resurgence, resistance, and research (second of two parts).	'Wyler DJ'	N Engl J Med. 1983 Apr 21;308(16):934-40.
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies.	'Hall R', 'McBride J', 'Morgan G', 'Tait A', 'Zolg JW', 'Walliker D', 'Scaife J'	Mol Biochem Parasitol. 1983 Mar;7(3):247-65.
Prospects for malaria blood stage vaccine (author's transl)	'Rieckmann KH'	Bol Oficina Sanit Panam. 1982 Jan;92(1):77-80.
Malaria: immunity and prospects for vaccination.	'Hommel M'	West J Med. 1981 Oct;135(4):285-99.
Host defenses in murine malaria: failure of vaccination with formolized blood parasites to protect athymic mice from Plasmodium berghei.	'Murphy JR', 'Carter PB', 'MacDonald TT'	Infect Immun. 1980 Aug;29(2):827-30.
Vaccination of chicks against Plasmodium gallinaceum by erythrocytic and exoerythrocytic parasites attenuated by gamma irradiation.	'Hughes HP', 'Dixon B'	Ann Trop Med Parasitol. 1980 Apr;74(2):115-26.
Recent advances in applied malaria immunology.	'Speer CA', 'Silverman PH'	Z Parasitenkd. 1979 Nov;60(1):3-17.
Immunity to malaria.	'Cohen S'	Proc R Soc Lond B Biol Sci. 1979 Jan 15;203(1153):323-45.
Development of a malaria vaccine.	'Cohen S'	J R Soc Med. 1978 Jul;71(7):476-8.
Summing up of the symposium: immunology and immunopathology of malaria.	'Greenblatt ChL', 'Cohen S', 'Brown KN', 'Meuwissen HE', 'Osunkoya BO', 'Spira DT'	Isr J Med Sci. 1978 Jun;14(6):712-7.
Malaria vaccine: the effect of sporozoite-induced immunity on exo-erythrocytic stages.	'Bafort JM', 'Pryor WH Jr', 'Beaudoin RL'	Ann Soc Belg Med Trop. 1978;58(1):63-4.
Plasmodium gallinaceum: vaccination in chickens.	'McGhee RB', 'Singh SD', 'Weathersby AB'	Exp Parasitol. 1977 Oct;43(1):231-8.
Merozoite vaccination of douroucouli monkeys against falciparum malaria.	'Mitchell GH', 'Richards WH', 'Butcher GA', 'Cohen S'	Lancet. 1977 Jun 25;1(8026):1335-8.
Current prospects and problems for a malaria vaccine.	'Miller LH'	J Infect Dis. 1977 May;135(5):855-64.
A critique of merozoite and sporozoite vaccines in malaria.	'Miller LH'	Adv Exp Med Biol. 1977;93:113-20.
Should cultivated exoerythrocytic parasites be considered as a source of antigen for a malaria vaccine?	'Beaudoin RL'	Bull World Health Organ. 1977;55(2-3):373-6.
Culture of malaria parasites.	'Butcher GA', 'Richards WH'	Trans R Soc Trop Med Hyg. 1977;71(4):277-8.
Stimulation of resistance in mice to sporozoite-induced Plasmodium berghei malaria by injections of avian exoerythrocytic forms.	'Holbrook TW', 'Spitalny GL', 'Palczuk NC'	J Parasitol. 1976 Oct;62(5):670-5.
Vaccination against Plasmodium knowlesi malaria.	'Brown KN', 'Tanaka A'	Trans R Soc Trop Med Hyg. 1975;69(3):350-3.
Plasmodium berghei: vaccination of mice against malaria with heat inactivated parasitized blood.	"D'Antonio LE"	Exp Parasitol. 1972 Feb;31(1):82-7.
Plasmodium: a resume of the isolation of the vaccine fraction by the French pressure cell technique.	"D'Antonio LE"	Exp Parasitol. 1972 Feb;31(1):75-81.
Immunological aspects of malaria infection.	'Brown IN'	Adv Immunol. 1969;11:267-349.
Active immunization of rats with a cell-free extract of the erythrocytic parasites of Plasmodium berghei.	'Zuckerman A', 'Hamburger Y', 'Spira D'	Exp Parasitol. 1967 Aug;21(1):84-97.